Lupin, Zydus sign licensing pact to co-market Saroglitazar Mg for chronic liver diseases in India EP News Bureau Nov 3, 2023 In 2020, Saroglitazar Mg received approval for the treatment of NASH and NAFLD
Zydus announces Phase IV EVIDENCES-XI trial to generate RWE of Saroglitazar Mg in NAFLD patients… EP News Bureau Jun 9, 2023 Phase IV EVIDENCES- XI trial will enroll approximately 1500 NAFLD patients with comorbidities
Zydus announces world’s first drug for the treatment of Non-Cirrhotic NASH EP News Bureau Mar 5, 2020 Saroglitazar, approved by DCGI becomes the first ever drug anywhere in the world for treatment of Non-Cirrhotic Non-Alcoholic…
